Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume

Journal of Neurology

Volumn 258, Issue 4, 2011, Pages 677-685

  Ormstad, Heidi ^a,b   Aass, Hans Christian Dalsbotten ^c   Lund Sørensen, Niels ^a   Amthor, Karl Friedrich ^a   Sandvik, Leif ^c  

^a Vestre Viken Hospital Trust   (Norway)

^b UNIVERSITY OF SOUTH EASTERN NORWAY   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute ischemic stroke; Anti inflammatory; Cytokines; Inflammation; Proinflammatory

Indexed keywords

C REACTIVE PROTEIN; CXCL1 CHEMOKINE; CYTOKINE; GLUCOSE; HEMOGLOBIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9;

AGED; ARTICLE; BLOOD SAMPLING; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VOLUMETRY;

EID: 79953806045     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6006-0     Document Type: Article

References (49)

1. McColl BW, Allan SM, Rothwell NJ (2009) Systemic infection, inflammation and acute ischemic stroke. Neuroscience 158:1049-1061
2. Wang Q, Tang XN, Yenari MA (2007) The inflammatory response in stroke. J Neuroimmunol 184:53-68 (Pubitemid 46365991)
3. Sairanen T, Carpen O, Karjalainen-Lindsberg ML, Paetau A, Turpeinen U, Kaste M, Lindsberg PJ (2001) Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke 32:1750-1758
4. Feuerstein GZ, Wang X, Barone FC (1998) The role of cytokines in the neuropathology of stroke and neurotrauma. Neuroimmunomodulation 5:143-159 (Pubitemid 28417026)
5. Stoll G, Jander S, Schroeter M (1998) Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 56:149-171 (Pubitemid 28432563)
6. Kriz J, Lalancette-Hébert M (2009) Inflammation, plasticity and real-time imaging after cerebral ischemia. Acta Neuropathol 117:497-509
7. Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, Hennerici M (1994) Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 122:135-139 (Pubitemid 24097260)
8. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, Tarkowski A (1995) Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26:1393-1398
9. Vila N, Castillo J, Dávalos A, Chamorro A (2000) Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31:2325-2329
10. Acalovschi D, Wiest T, Hartmann M, Farahmi M, Mansmann U, Auffarth GU, Grau AJ, Green FR, Grond-Ginsbach C, Schwaninger M (2003) Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 34:1864-1870
11. Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, Barberan EM, del Zoppo GJ, Hallenbeck JM, Rothwell NJ, Hopkins SJ, Tyrrell PJ (2004) Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 4:2
12. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C, Emsley HC, Forconi S, Hopkins SJ, Masotti L, Muir KW, Paciucci A, Papa F, Roncacci S, Sander D, Sander K, Smith CJ, Stefanini A, Weber D (2005) Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for Health Care Professionals from the CRP Pooling Project Members. Stroke 36:1316-1329 (Pubitemid 40798763)
13. Smith CJ, Emsley HCA, Vail A, Georgiou RF, Rothwell NJ, Tyrrell PJ, Hopkins SJ (2006) Variability of the systemic acute phase response after ischemic stroke. J Neurol Sci 251:77-81 (Pubitemid 44792143)
14. Sotgiu S, Zanda B, Marchetti B, Fois ML, Arru G, Pes GM, Salaris FS, Arru A, Pirisi A, Rosati G (2006) Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol 13:505-513 (Pubitemid 43823367)
15. Licata G, Tuttolomondo A, Di Raimondo D, Corrao S, Di Sciacca R, Pinto A (2009) Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke. Thromb Haemost 101:929-937
16. Lerdal A, Bakken LN, Rasmussen EF, Beiermann C, Ryen S, Pynten S, Drefvelin AS, Dahl AM, Rognstad G, Finset A, Lee KA, Kim HS (2011) Physical impairment, depressive symptoms and pre-stroke fatigue are related to fatigue in the acute phase after stroke. Disabil Rehabil 33:334-342
17. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35-41
18. Collin C, Wade DT, Davies S, Horne V (1988) The Barthel ADL Index: a reliability study. Int Disabil Stud 10:61-63
19. Wolfe CDA, Taub NA, Woodrow EJ, Burney PGJ (1991) Assessment of scales of disability and handicap for stroke patients. Stroke 22:1242-1244
20. Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR (1995) Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 37:800-804
21. Ferrarese C, Mascarucci P, Zoia C, Cavarretta R, Frigo M, Begni B, Sarinella F, Frattola L, De Simoni MG (1999) Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab 19:1004-1009 (Pubitemid 30173723)
22. Emsley HC, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, Hallenbeck JM, del Zoppo GJ, Rothwell NJ, Tyrrell PJ, Hopkins SJ (2003) An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 139:93-101 (Pubitemid 36694395)
23. Mazzotta G, Sarchielli P, Caso V, Paciaroni M, Floridi A, Floridi A, Gallai V (2004) Different cytokine levels in thrombolysis patients as predictors for clinical outcome. Eur J Neurol 11:377-381 (Pubitemid 39272941)
24. Waje-Andreassen U, Krakenes J, Ulvestad E, Thomassen L, Myhr KM, Aarseth J, Vedeler CA (2005) IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol Scand 111:360-365 (Pubitemid 40705305)
25. Basic Kes V, Simundic AM, Nikolac N, Topic E, Demarin V (2008) Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. Clin Biochem 41:1330-1334
26. Suzuki S, Tanaka K, Suzuki N (2009) Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab 29:464-479
27. Emsley HCA, Smith C, Gavin CM, Georgiou RF, Vail A, Barberan EM, Illingworth K, Scarth S, Wickramasinghe V, Hoadley ME, Rothwell NJ, Tyrrell PJ, Hopkins SJ (2007) Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurology 7:5
28. Zaremba J, Skrobanski P, Losy J (2001) Tumour necrosis factoralpha is increased in the cerebrospinal fluid and serum of ischaemic stroke patients and correlates with the volume of evolving brain infarct. Biomed Pharmacother 55:258-263 (Pubitemid 32595480)
29. Shalaby MR, Waage A, Aarden L, Espevik T (1989) Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol 53:488-498 (Pubitemid 19284841)
30. Hirano T (1992) The biology of interleukin-6. Chem Immunol 51:153-180
31. Tilg H, Trehu E, Atkins MB (1994) Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83:113-118 (Pubitemid 24016522)
32. Beamer NB, Coull BM, Clark WM, Briley DP, Wynn M, Sexton G (1998) Persistent inflammatory response in stroke survivors. Neurology 50:1722-1728 (Pubitemid 28283241)
33. Zaremba J, Losy J (2006) Interleukin-12 in acute ischemic stroke patients. Folia Neuropathol 44:59-66
34. Zaremba J, Losy J (2003) Interleukin-18 in acute ischemic stroke patients. Neurol Sci 24:117-124 (Pubitemid 37304279)
35. Yuen CM, Chiu CA, Chang LT, Liou CW, Lu CH, Youssef AA, Yip HK (2007) Level and value of interleukin-18 after acute ischemic stroke. Circ J 71:1691-1696 (Pubitemid 350240087)
36. Kostulas N, Pelidou SH, Kivisakk P, Kostulas V, Link H (1999) Increased IL-1β, IL-8, and IL-17 mRNA Expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke 30:2174-2179
37. Al-Bahrani A, Taha S, Shaath H, Bakhiet M (2007) TNF-α and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents. Curr Neurovasc Res 4:31-37 (Pubitemid 46280289)
38. Pedersen ED, Waje-Andreassen U, Vedeler CA, Aamodt G, Mollnes TE (2004) Systemic complement activation following human acute ischaemic stroke. Clin Exp Immunol 137:117-122 (Pubitemid 38869785)
39. Kelly-Hayes M, Beiser A, Kase CS, Scaramucci A, D'Agostino RB, Wolf PA (2003) The influence of gender and age on disability following ischemic stroke: the Framingham study. J Stroke Cerebrovasc Dis 12:119-126 (Pubitemid 36870484)
40. Bhalla A, Grieve R, Tilling K, Rudd AG, Wolfe CD (2004) Older stroke patients in Europe: stroke care and determinants of outcome. Age Ageing 33:618-624 (Pubitemid 39504297)
41. Koton S, Tanne D, Green MS, Bornstein NM (2010) Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first national acute stroke Israeli survey (NASIS 2004). Neuroepidemiology 34:90-96
42. Losy J, Zaremba J, Skrobañski P (2005) CXCL1 (GRO-alpha) chemokine in acute ischaemic stroke patients. Folia Neuropathol 43:97-102 (Pubitemid 40975404)
43. Fontaine RH, Cases O, Lelieœvre V, Mesplès B, Renauld JC, Loron G, Degos V, Dournaud P, Baud O, Gressens P (2008) (2008). IL-9/IL-9 receptor signaling selectively protects cortical neurons against developmental apoptosis. Cell Death Differ 15:1542-1552
44. Vila N, Castillo J, Dávalos A, Esteve A, Planas AM, Chamorro Á (2003) Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke 34:671-675 (Pubitemid 36307391)
45. Nayak AR, Kashyap RS, Purohit HJ, Kabra D, Taori GM, Daginawala HF (2009) Evaluation of the inflammatory response in sera from acute ischemic stroke patients by measurement of IL-2 and IL-10. Inflamm Res 58:687-691
46. Marquardt L, Ruf A, Mansmann U, Winter R, Buggle F, Kallenberg K, Grau AJ (2005) Inflammatory response after acute ischemic stroke. J Neurol Sci 236:65-71 (Pubitemid 41218694)
47. Kostulas N, Kivisakk P, Huang Y, Matusevicius D, Kostulas V, Link H (1998) Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA. Stroke 29:462-466 (Pubitemid 28086692)
48. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU (2001) Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 32:2735-2740 (Pubitemid 33134456)
49. Shenhar-Tsarfaty S, Assayag EB, Bova I, Shopin L, Berliner S, Shapira I, Bornstein NM (2008) Early signaling of inflammation in acute ischemic stroke: clinical and rheological implications. Thromb Res 122:167-173 (Pubitemid 351754919)